)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Bacil Pharma
Bacil Pharma (524516) investor relations material
Bacil Pharma Q4 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 25/26 earnings summary22 May, 2026
Executive summary
Audited financial results for the quarter and year ended 31 March 2026 were approved, with the company continuing to have no significant operations during the year.
The audit opinion is unmodified, confirming compliance with Indian Accounting Standards and regulatory requirements.
Financial highlights
Total revenue for the year ended 31 March 2026 was ₹198.50 lakhs, up from ₹170.62 lakhs year-over-year.
Net profit before tax for the year was ₹3.89 lakhs, a sharp decline from ₹40.76 lakhs in the previous year.
Other comprehensive income showed a significant loss of ₹226.30 lakhs due to fair valuation of financial assets.
Net loss for the year after comprehensive income was ₹164.14 lakhs.
Cash and cash equivalents at year-end decreased to ₹56.85 lakhs from ₹285.73 lakhs.
Outlook and guidance
Management expects to restart operations, with current assets exceeding current liabilities and no material uncertainty regarding the company’s ability to meet obligations in the next year.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bacil Pharma
- Quarterly net profit rose to ₹3.92 lakhs with improved revenue and clean auditor review.524516
Q3 25/2616 Feb 2026 - Quarterly loss before tax, but profit after OCI; auditor flags loan recoverability concerns.524516Q1 24/2521 Nov 2025
- Q2 FY25 saw a sharp turnaround to profit and revenue growth, but loan recoverability remains uncertain.524516Q2 24/2521 Nov 2025
- Sharp drop in revenue and profit, with auditors issuing a disclaimer due to major uncertainties.524516Q2 25/2613 Nov 2025
- Profit rebounded sharply in Q1 FY26, but auditor raised concerns over fund application.524516Q1 25/2612 Aug 2025
- FY25 saw significant revenue and profit growth, but loan recoverability remains a concern.524516Q4 24/256 Jun 2025
- Net loss in Q3 FY25, no core revenue, and auditor flags loan recoverability concerns.524516Q3 24/256 Jun 2025
Next Bacil Pharma earnings date
Q1 26/2711 Aug, 2026
Bacil Pharma
Next Bacil Pharma earnings date
Q1 26/2711 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage